LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 PD0325901
0.04
uM
LJP5
 0.9275 0.0705 0.8972 0.0993
BT-20 PD0325901
0.04
uM
LJP6
 0.9135 0.0224 0.8760 0.0305
BT-20 PD173074
0.04
uM
LJP6
 1.0620 0.0178 1.0894 0.0251
BT-20 PD184352
0.04
uM
LJP5
 1.0587 0.0187 1.0842 0.0255
BT-20 Pelitinib
0.04
uM
LJP5
 0.9869 0.0325 0.9819 0.0460
BT-20 PF431396
0.04
uM
LJP5
 0.9340 0.0206 0.9044 0.0294
BT-20 PF477736
0.04
uM
LJP5
 0.9217 0.0182 0.8854 0.0291
BT-20 PF562271
0.04
uM
LJP6
 0.9177 0.0104 0.8814 0.0130
BT-20 PHA-665752
0.04
uM
LJP5
 1.0323 0.0064 1.0467 0.0087
BT-20 PHA-793887
0.04
uM
LJP6
 0.6225 0.0312 0.4530 0.0458
BT-20 PI103
0.04
uM
LJP6
 0.9384 0.0427 0.9123 0.0599
BT-20 PLX-4720
0.04
uM
LJP5
 1.0292 0.0141 1.0429 0.0207
BT-20 QL-X-138
0.04
uM
LJP6
 0.7694 0.0268 0.6668 0.0351
BT-20 QL-XII-47
0.04
uM
LJP6
 0.7311 0.1230 0.6148 0.1708
BT-20 Radicicol
0.04
uM
LJP5
 0.8706 0.0232 0.8120 0.0350
BT-20 Radicicol
0.04
uM
LJP6
 0.8612 0.0561 0.8018 0.0778
BT-20 Seliciclib
0.04
uM
LJP5
 1.0355 0.0023 1.0514 0.0025
BT-20 Ruxolitinib
0.04
uM
LJP5
 0.9917 0.0323 0.9896 0.0475
BT-20 XL147
0.04
uM
LJP5
 1.0837 0.0288 1.1201 0.0396
BT-20 Saracatinib
0.04
uM
LJP6
 0.9756 0.0282 0.9648 0.0400
BT-20 Selumetinib
0.04
uM
LJP6
 1.0692 0.0426 1.1019 0.0622
BT-20 Sirolimus
0.04
uM
LJP6
 0.6345 0.0036 0.4704 0.0104
BT-20 Sorafenib
0.04
uM
LJP6
 0.9289 0.0133 0.8976 0.0174
BT-20 SU11274
0.04
uM
LJP5
 1.0714 0.0210 1.1034 0.0298
BT-20 Fedratinib
0.04
uM
LJP5
 1.0545 0.0177 1.0784 0.0243